BK
74
2
ACN
52
3
CA
38
6
IR
66
3
CFG
70
6
WDC
47
4
CINF
53
2
CCI
31
3
HD
57
2
MAS
58
2
FE
50
-2
DG
6
2
LEG
36
4
STZ
54
-3
SNA
68
-2
GIS
31
3
PLD
56
8
ROK
62
15
M
37
12
AAP
24
6
BK
74
2
ACN
52
3
CA
38
6
IR
66
3
CFG
70
6
WDC
47
4
CINF
53
2
CCI
31
3
HD
57
2
MAS
58
2
FE
50
-2
DG
6
2
LEG
36
4
STZ
54
-3
SNA
68
-2
GIS
31
3
PLD
56
8
ROK
62
15
M
37
12
AAP
24
6
Financhill
Back

Nebius Group NV 10K Form

Sell
45

NBIS
Nebius Group NV

Last Price:
23.52
Seasonality Move:
0.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NBIS News And Ratings

See the #1 stock for the next 7 days that we like better than NBIS

NBIS Financial Statistics

Sales & Book Value

Annual Sales: $9.04B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $14.42
Price / Book: 1.65

Profitability

EPS (TTM): -0.63500
Net Income (TTM): $-155.45M
Gross Margin: $4.97B
Return on Equity: -4.57%
Return on Assets: -2.41%

Nebius Group NV Earnings Forecast

Key Nebius Group NV Financial Ratios

  • The Gross Profit Margin over the past 4 years for NBIS is 55.00%.
  • The Selling, General & Administrative Expenses for NBIS have been equal to 33.44% of Gross Profit Margin.
  • The Research & Development expenses have been 12.87% of Revenue.
  • The Interest Expense is 54.67% of Operating Income.
  • The Net Earning history of NBIS is 2.48% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Nebius Group NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Interactive Media & Services
Sector: Communication Services
Current Symbol: NBIS
Website: group.nebius.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 22.24
Quick Ratio: 21.85

Price-to-Earnings

Trailing P/E Ratio: 39.04
Forward P/E Ratio: 0

NBIS Technical Analysis vs Fundamental Analysis

Sell
45
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy or a Sell?

  • Nebius Group NV stock is rated a Sell
    The current Nebius Group NV [NBIS] share price is $23.49. The Score for NBIS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.